2023 Functional Genomics of Human Brain Development and Disease Gordon Research Conference

点击翻译按钮获取中文摘要

Project Summary/Abstract This 2023 Functional Genomics of Human Brain Development and Disease GRC conference seeks to bring together a multidisciplinary and diverse group of geneticists, neuroscientists, and stem cell biologists endeavoring to improve diagnostics, prognostics, and treatment of brain disease. The conference will explore (1) genomics of brain diseases, (2) applications of high-throughput genomic assays and screens, (3) technological advances in reprogramming, differentiation, and genome-engineering; (4) new insights into human brain development and disorders obtained through technologies; and (5) progress towards novel therapeutic targets and interventions. Whereas large-scale genomic studies are uncovering the complex genetic architecture of gene regulation and disease risk, the causal cellular mechanisms of disease risk and progression remain unclear. While the generation of patient-specific neurons, glia, and organoids facilitate the study of human brain development, CRISPR-based engineering approaches facilitate single or genome-wide perturbations in DNA sequence or epigenetic activity; their integration makes it possible to investigate the molecular mechanisms of disease-associated variations. Together, these approaches translate the myriad advances from large-scale genetic studies into clinically actionable information. This 2023 Functional Genomics of Human Brain Development and Disease GRC conference will contribute to improving our understanding the cellular and molecular mechanisms involved in regulating human brain development in health and disease. The attendees are also expected to form new connections with the leaders in industry and academia for setting new collaborations and starting new careers.